Export 4 results:
Sort by: Type [ Year (Desc)]
Filters: Author is Chen, W.  [Clear All Filters]
2023 (1)
Ramos P., Carvalho M. R., Chen W., Yan L., Zhang, C.-H., He, Yu-Long, Reis R. L., and Oliveira J. M., "Microphysiological systems to study colorectal cancer: State-of-the-art", Biofabrication, doi:10.1088/1758-5090/acc279, 2023.
Popup
Icon RepositoriUM
2022 (1)
Li H., Wang C., Lan L., Yan L., Li W., Evans I., Josue Ruiz E., Su Q., Zhao G., Wu W., Zhou Z., Hu Z., Chen W., Oliveira J. M., Behrens A., Reis R. L., and Zhang C., "METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability", Cellular and Molecular Life Sciences, vol. 79, issue 135, doi:10.1007/s00018-022-04129-0, 2022.
Popup
Icon RepositoriUM
2021 (2)
Zhang S. - W., Chen W., Lu X. - F., Wen Z., Hu L., Liu Y. - H., Yang Z., Xue L., Su Q., Yan L. P., Oliveira J. M., Reis R. L., He, Yu-Long, and Zhang, C.-H., "An efficient and user-friendly method for cytohistological analysis of organoids", Journal of Tissue Engineering and Regenerative Medicine, doi:10.1002/term.3248, 2021.
Popup
Li H., Wang C., Lan L., Wu W., Evans I., Josue Ruiz E., Yan L. P., Zhou Z., Oliveira J. M., Reis R. L., Hu Z., Chen W., He Y., and Zhang C., "PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway", Frontiers in Cell and Developmental Biology, doi:10.3389/fcell.2021.719192, 2021.
Popup

Back to top